Lactic Acid

Lactic Acid

SCHEMBL692985

CC(O)C(=O)O.CC(O)CO

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CHRM1DRD2DRD3DRD4HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR2APDE3ASIGMAR1

The experimentally established mechanism targets of Lactic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.69
TDP1 Q9NUW8 1/20 0.62
OR51E2 Q9H255 1/20 0.50
PDE4A P27815 1/20 0.40
TSHR P16473 3/20 0.39
USP2 O75604 1/20 0.37
SLCO1B1 Q9Y6L6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lactic Acid SCHEMBL8850838 1.00 TP53 (0.69) TP53TDP1OR51E2PDE4ATSHR
Lactic Acid SCHEMBL3058015 0.92 TP53 (0.58) TP53TDP1OR51E2PDE4AUSP2
Propylene Glycol SCHEMBL3270603 0.88 TDP1 (0.62) TP53TDP1OR51E2PDE4ATSHR
Propylene Glycol SCHEMBL5603965 0.88 TDP1 (0.62) TP53TDP1OR51E2PDE4ATSHR
Lactic Acid SCHEMBL28016953 0.88 TP53 (0.69) TP53TDP1OR51E2PDE4ATSHR
Propylene Glycol SCHEMBL17841687 0.88 TDP1 (0.62) TP53TDP1OR51E2PDE4ATSHR
Propylene Glycol SCHEMBL320017 0.87
Propylene Glycol SCHEMBL4337036 0.87 TDP1 (0.71) TP53TDP1OR51E2PDE4ATSHR
Lactic Acid SCHEMBL28421499 0.87
Propylene Glycol SCHEMBL28574118 0.87 TDP1 (0.71) TP53TDP1OR51E2PDE4ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112370634-B Composite pipe and preparation method and application thereof 山东华安生物科技有限公司 2023-04-25 CN claimed
US-20160194455-A1 Silicone Elastomer Gels and Related Hydrosilylation Processes ALZO INT INC (US) 2016-07-07 US claimed
US-20150274972-A1 ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING ALZO INTERNATIONAL, INC. (US) 2015-10-01 US claimed
EP-2906614-A1 ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING Alzo International, Inc. (US) 2015-08-19 EP claimed
WO-2015048228-A2 IMPROVED SILICONE ELASTOMER GELS AND RELATED HYDROSILYLATION PROCESSES ALZO INTERNATIONAL, INC. (US) 2015-04-02 WO claimed
CN-103432091-A Improved-performance tablet and preparation method thereof ZHONG SHUGUANG 2013-12-11 CN claimed
EP-2421377-A1 SHELF-LIFE EXTENSION OF SOUR DOUGH BAKED GOODS Ernst Böcker GmbH & Co. KG (DE) 2012-02-29 EP claimed
WO-2010122165-A1 SHELF-LIFE EXTENSION OF SOUR DOUGH BAKED GOODS ERNST BÖCKER GMBH & CO. KG (DE) 2010-10-28 WO claimed
EP-2243375-A1 Durability extension of baked sourdough goods Ernst Böcker GmbH & Co. KG (DE) 2010-10-27 EP claimed
US-20260090970-A1 POLYTERPENE FILM FORMER FOR COSMETIC APPLICATIONS MOMENTIVE PERFORMANCE MAT INC (US) 2026-04-02 US disclosed
US-20250354008-A1 BIO-DERIVED GREEN PARTICLE COMPOSITIONS AND METHODS THEREOF MOMENTIVE PERFORMANCE MAT INC (US) 2025-11-20 US disclosed
US-20250213460-A1 NATURAL DERIVED FILM FORMER FOR COSMETIC APPLICATIONS MOMENTIVE PERFORMANCE MATERIALS INC. 2025-07-03 US disclosed
WO-2025132800-A1 PERSONAL CARE COMPOSITIONS COMPRISING LACTIC ACID ESTERS BASF SE (DE) 2025-06-26 WO disclosed
CN-112996590-B Microencapsulation using high voltage low current high frequency ac spray atomization 福纳技术有限责任公司 2024-04-09 CN disclosed
US-5830501-A DRUG DELIVERY TO MUCOSAL TISSUE, SEMIPERMEABLE WALL, PRECIPITATION ALZA CORPORATION (US) 1998-11-03 US disclosed
US-5713852-A Oral dosage and method for treating painful conditions of the oral cavity ALZA CORPORATION (US) 1998-02-03 US disclosed
US-5348746-A Method for administering drug ALZA CORPORATION (US) 1994-09-20 US disclosed
US-5266332-A Oral administering of drugs with semipermeable walls and multicompartment polymer with electrolyte ALZA CORPORATION (US) 1993-11-30 US disclosed
US-5254349-A Flocculating drug and hydrophilic polymer in dosage form ALZA CORPORATION (US) 1993-10-19 US disclosed
US-5200195-A Reducing stickiness of a dosage for to biological tissue in fluid environment of use ALZA CORPORATION (US) 1993-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250213460-A1 NATURAL DERIVED FILM FORMER FOR COSMETIC APPLICATIONS DSG1, CUTA, CDH1 TP53 1525/4885TDP1 1472/4885OR51E2 1767/4885
US-20150274972-A1 ENHANCED WATER AND TRANSFER RESISTANT FILM FORMING CUTA, TRRAP, LCP1 TP53 1165/4885TDP1 1235/4885OR51E2 3536/4885
US-20260090970-A1 POLYTERPENE FILM FORMER FOR COSMETIC APPLICATIONS CUTA, LIPE, TNK1 TP53 1070/4885TDP1 1171/4885OR51E2 278/4885
US-20160194455-A1 Silicone Elastomer Gels and Related Hydrosilylation Processes ITCH, MMS19, STS TP53 1647/4885TDP1 2691/4885OR51E2 436/4885
US-20250354008-A1 BIO-DERIVED GREEN PARTICLE COMPOSITIONS AND METHODS THEREOF ALG1, PARG, RECQL TP53 140/4885TDP1 97/4885OR51E2 2441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.